Le Lézard
Classified in: Health, Business
Subject: OFR

Healthcare Trust Prices Public Offering of 1,400,000 Shares of 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock


NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Healthcare Trust, Inc. ("HTI" or the "Company") today announced the pricing of an underwritten public offering of 1,400,000 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") at a public offering price of $25.00 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 210,000 shares of Series A Preferred Stock. The shares of Series A Preferred Stock have been approved for listing and are expected to begin trading on The Nasdaq Global Market on December 11, 2019 under the symbol "HTIA." The Series A Preferred Stock will have a $25.00 liquidation preference per share. 

Healthcare Trust Inc. (PRNewsfoto/Healthcare Trust, Inc.)

The Company expects to receive net proceeds from the offering before expenses and structuring fee of approximately $33.9 million and expects to close the transaction on or about December 11, 2019. The Company plans to contribute the net proceeds it receives from the offering to its operating partnership in exchange for a new class of preferred units, which will have economic interests that are substantially similar to the designations, preferences and other rights of the Series A Preferred Stock. The Company, acting through its operating partnership, intends to use the net proceeds from this contribution for general corporate purposes, which may include purchases of additional properties. 

The joint bookrunning managers for the offering are B. Riley FBR, Inc., D.A. Davidson & Co., Ladenburg Thalmann & Co. Inc. and William Blair & Company, L.L.C. Co-managers for the offering are National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (Nasdaq:NHLD), Boenning & Scattergood, Inc. and Wedbush Securities Inc.

The Series A Preferred Stock was offered pursuant to a preliminary prospectus forming part of the registration statement which was declared effective by the Securities and Exchange Commission (the "Commission") on December 5, 2019.

About Healthcare Trust, Inc.

Healthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States. Additional information about HTI can be found on its website at www.healthcaretrustinc.com.

Important Notice

This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. The offering of securities is made only by means of a prospectus. Copies of the final prospectus relating to these securities, when available, may be obtained from B. Riley FBR, Inc. You should direct any requests to B. Riley FBR, Inc., Attention: Prospectus Department, 1300 17th Street North, Suite 1300, Arlington, Virginia 22209, by telephone at (703) 312-9580 or by email at [email protected]; to D.A. Davidson & Co., Attn: Syndicate Dept., 8 3rd Street North, Great Falls, MT 59401, [email protected], (800) 332-5915; to Ladenburg Thalmann & Co. Inc., Attention: Syndicate Department, 277 Park Avenue 26th Floor, New York, New York 10172; or to: William Blair & Company, L.L.C., Attn: Prospectus Department, 150 North Riverside Plaza, Chicago, Illinois 60606, Telephone: (800) 621-0687, Email: [email protected]. You may also obtain a copy of the final prospectus, when available, and other documents the Company has filed with the Commission for free by visiting the Commission's website at http://www.sec.gov.

The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. In addition, words such as "may," "will," "seeks," "anticipates," "believes," "estimates," "expects," "plans," "intends," "should" or similar expressions indicate a forward-looking statement, although not all forward-looking statements include these words. Actual results may differ materially from those contemplated by such forward-looking statements, including those set forth in the Risk Factors section of HTI's registration statement on Form S-11 and other reports filed with the Commission. Further, forward-looking statements speak only as of the date they are made, and HTI undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required by law.

SOURCE Healthcare Trust, Inc.


These press releases may also interest you

at 18:15
Americas Gold and Silver Corporation ("Americas" or the "Company"), a growing North American precious metals producer, reports consolidated financial and operational results for the year ended December 31, 2023. This earnings release should be...

at 18:15
Westhaven Gold Corp. is pleased to announce that it has closed the final tranche of the non-brokered private placement announced on February 20, 2024. Westhaven has issued a total of 7,926,182 common shares that qualify as "flow-through shares" of...

at 18:03
Revenue Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's  sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31. Twelve-month...

at 18:02
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...

at 18:01
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: